Opuntia ficus-indica and its potential effects on cancer
DOI:
https://doi.org/10.22317/jcms.v9i5.1430Keywords:
Cancer, OFI, prickly pear, anticancer, chemoprevention, antioxidantsAbstract
Cancer is the second leading cause of death worldwide, with an estimated 19.3 million new cases and 10.0 million deaths in 2021. Genetic and environmental factors, including nutrition, play an important role in cancer development. At present, health professionals and the public have become highly interested in natural products and healthy food for preventing or treating cancer. Several natural products, such as fruits and vegetables, have demonstrated anticancer effects. Opuntia ficus-indica (OFI), commonly known as prickly pear or cactus pear, is a plant that has numerous beneficial properties. It serves as a source of dietary fibres, vitamins and various bioactive compounds with diverse health benefits. These compounds are associated with anti-inflammatory, antioxidant, antimicrobial, hypoglycaemic and neuroprotective properties. Different parts of the plant, including the fruit pulp and peel, cladodes (pads) and seeds, have been scientifically studied, and they have demonstrated therapeutic potential while being considered safe for human consumption. However, there is limited awareness and scientific information about OFI as a fruit. Reviewing existing knowledge and research on it is necessary to shed light on its potential anticancer properties. By consolidating the available information on OFI, we can gain a better understanding of this fruit and its potential role in cancer prevention and treatment.
References
World Health Organization (WHO). Cancer 3 February 2022 [Available from:https://www.who.int/news-room/fact-sheets/detail/cancer.
Amin AR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. Journal of Clinical Oncology. 2009;27(16):2712.
Donaldson MS. Nutrition and cancer: a review of the evidence for an anticancer diet. Nutrition Journal. 2004;3(1):1–21.
Haddad RI, Shin DM. Recent advances in head and neck cancer. New England Journal of Medicine. 2008;359(11):1143–54.
Berenblum I. The modifying influence of dichloro‐ethyl sulphide on the induction of tumours in mice by tar. The Journal of Pathology and Bacteriology. 1929;32(3):425–34.
Sporn MB, Dunlop N, Newton D, Smith J, editors. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Federation Proceedings; 1976.
Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. New England Journal of Medicine. 1986;315(24):1501–5.
Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. New England Journal of Medicine. 1993;328(1):15–20.
Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. New England Journal of Medicine. 1990;323(12):795–801.
Benner SE, Pajak TF, Lippman SM, Earley C, Hong WK. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. JNCI: Journal of the National Cancer Institute. 1994;86(2):140–1.
Shin DM, Khuri FR, Murphy B, Garden AS, Clayman G, Francisco M, et al. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. Journal of Clinical Oncology. 2001;19(12):3010–7.
Arber N, Eagle CJ, Spicak J, Rácz I, Dite P, Hajer J, et al. Celecoxib for the prevention of colorectal adenomatous polyps. New England Journal of Medicine. 2006;355(9):885–95.
Khuri FR, Cohen V. Molecularly targeted approaches to the chemoprevention of lung cancer. Clinical Cancer Research. 2004;10(12):4249s–53s.
Zhang Z, Wang Y, Lantry LE, Kastens E, Liu G, Hamilton AD, et al. Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf. Oncogene. 2003;22(40):6257–65.
Choe MS, Zhang X, Shin HJC, Shin DM, Chen Z. Interaction between epidermal growth factor receptor–and cyclooxygenase 2–mediated
pathways and its implications for the chemoprevention of head and neck cancer. Molecular Cancer Therapeutics. 2005;4(9):1448–55.
Reddy L, Odhav B, Bhoola K. Natural products for cancer prevention: a global perspective. Pharmacology & Therapeutics. 2003;99(1):1–13.
Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutrition and Cancer. 1992;18(1):1–29.
Benetou V, Orfanos P, Lagiou P, Trichopoulos D, Boffetta P, Trichopoulou A. Vegetables and fruits in relation to cancer risk: evidence from the Greek EPIC cohort study. Cancer Epidemiology Biomarkers & Prevention. 2008;17(2):387–92.
Freedman ND, Park Y, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A, et al. Fruit and vegetable intake and head and neck cancer risk in a large United States prospective cohort study. International Journal of Cancer. 2008;122(10):2330–6.
Fagundes MdA, Silva ARC, Fernandes GA, Curado MP. Dietary Polyphenol Intake and Gastric Cancer: A Systematic Review and Meta-Analysis. Cancers. 2022;14(23):5878.
Sakai M, Kitagawa Y, Saeki H, Miyazaki T, Yamaji T, Nemoto K, et al. Fruit and vegetable consumption and risk of esophageal cancer in the Asian region: a systematic review and meta-analysis. Esophagus. 2022:1–12.
García-Lavandeira JA, Ruano-Ravina A, Torres-Durán M, Parente-Lamelas I, Provencio M, Varela-Lema L, et al. Fruits and Vegetables and Lung Cancer Risk in Never Smokers. A Multicentric and Pooled Case-Control Study. Nutrition and Cancer. 2022;74(2):613–21.
Chang H-P, Huang M-C, Lei Y-P, Chuang Y-J, Wang C-W, Sheen L-Y. Phytochemical-rich vegetable and fruit juice alleviates oral mucositis during concurrent chemoradiotherapy in patients with locally advanced head and neck cancer. Journal of Traditional and Complementary Medicine. 2022;12(5):488–98.
Lu Y-T, Gunathilake M, Kim J. The influence of dietary vegetables and fruits on endometrial cancer risk: A meta-analysis of observational studies. European Journal of Clinical Nutrition. 2023;77(5):561–73.
Furdak P, Pieńkowska N, Bartosz G, Sadowska-Bartosz I. Extracts of Common Vegetables Inhibit the Growth of Ovary Cancer Cells. Foods. 2022;11(16):2518.
Yan H, Cui X, Zhang P, Li R. Fruit and vegetable consumption and the risk of prostate cancer: a systematic review and meta-analysis. Nutrition and Cancer. 2022;74(4):1235–42.
Wigner P, Bijak M, Saluk-Bijak J. Clinical potential of fruit in bladder cancer prevention and treatment. Nutrients. 2022;14(6):1132.
Bajalia EM, Azzouz FB, Chism DA, Giansiracusa DM, Wong CG, Plaskett KN, et al. Phytochemicals for the prevention and treatment of renal cell carcinoma: preclinical and clinical evidence and molecular mechanisms. Cancers. 2022;14(13):3278.
Zhao L, Jin L, Petrick JL, Zeng H, Wang F, Tang L, et al. Specific botanical groups of fruit and vegetable consumption and liver cancer and chronic liver disease mortality: a prospective cohort study. The American Journal of Clinical Nutrition. 2023;117(2):278–85.
Nam SY, Jo J, Lee WK, Cho CM. The sex discrepancy effects of fruit and vegetable intake on pancreatic cancer risk; a large Korean cancer screening cohort study. Digestive and Liver Disease. 2022;54(3):365–70.
Dusak A, Atasoy N, Demir H. Nutrition and Colon Cancer. Int J Acad Med Pharm. 2022;4(1):80–5.
Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. Journal of the American Dietetic Association. 1996;96(10):1027–39.
Aghajanpour M, Nazer MR, Obeidavi Z, Akbari M, Ezati P, Kor NM. Functional foods and their role in cancer prevention and health promotion: a comprehensive review. American Journal of Cancer Research. 2017;7(4):740.
ClinicalTrials.gov USNLoM. 2023.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Contemporary Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
